Science & Enterprise subscription

Follow us on Twitter

  • Another way to connect 100 million people end-to-end with Covid-19 vaccines. https://t.co/wIWk0XNDhv
    about 13 hours ago
  • New post on Science and Enterprise: Celebrating the New Administration https://t.co/5ErPGhVDEN #Science #Business
    about 19 hours ago
  • A company applying Crispr gene-editing technology to treat inherited heart disease is raising $94 million in its se… https://t.co/2QgwrBLIQd
    about 2 days ago
  • New post on Science and Enterprise: Crispr Heart Disease Biotech Raises $94M in New Funds https://t.co/XJHC82ALY3 #Science #Business
    about 2 days ago
  • A vaccine protecting against multiple Covid-19 viral variations is in development, with an early-stage clinical tri… https://t.co/ZkSq0jOpmg
    about 2 days ago

Please share Science & Enterprise

University, Biotech, Life Technologies Partner on Gene Tests

DNA Strands (NIST.gov)

(NIST.gov)

University at Buffalo in New York, the biotechnology company Empire Genomics, and genetics systems developer Life Technologies are establishing facilities at the university to conduct genomic sequencing for research and diagnostics to support personalized medicine. Financial terms of the partnership were not disclosed.

Under the deal, Life Technologies is providing equipment from its Ion line of semiconductor sequencing systems that translate the chemical information in DNA strands to a digital format for further analysis and processing. The sequence of the chemical information in DNA determines similarities and differences among human organisms. The facilities, which are expected to meet Clinical Laboratory Improvement Amendments standards for medical testing labs, will be housed at the university’s medical campus in downton Buffalo.

The university’s New York State Center of Excellence in Bioinformatics and Life Sciences will use the new sequencing facilities with Empire Genomics to conduct research leading to development of more precise diagnostics based on a person’s individual genome, and eventually treatments customized for that individual. The Center of Excellence connects life scientists at the university and two affiliated research centers — Roswell Park Cancer Institute and Hauptman-Woodward Medical Research Institute — to financial and industrial resources for business and economic development. The Center of Excellence also supports translational research with commercial potential.

Empire Genomics is a spin-off company from Roswell Park Cancer Institute that develops genomics tools for research, diagnostics, and drug discovery.  Norma Jean Nowak, the founder and chief scientist of Empire Genomics, is also science director at the Center of Excellence, and director of the Microarray and Genomics Facility, a collaborative research lab shared by Roswell Park Cancer Institute and University at Buffalo.

Earlier this year Roswell Park Cancer Institute purchased six Ion sequencers from Life Technologies for the institute’s Center for Personalized Medicine. In April, Life Technologies was acquired by Thermo Fisher Scientific, a manufacturer of laboratory equipment and systems for $13.6 billion.

Read more:

*     *     *

Comments are closed.